John Niederhuber - Net Worth and Insider Trading

John Niederhuber Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John Niederhuber owns 2 companies in total, including Aptevo Therapeutics Inc (APVO) , and Emergent BioSolutions Inc (EBS) .

Click here to see the complete history of John Niederhuber’s form 4 insider trades.

Insider Ownership Summary of John Niederhuber

Ticker Comapny Transaction Date Type of Owner
APVO Aptevo Therapeutics Inc 2016-08-01 director
EBS Emergent BioSolutions Inc 2010-08-23 director

John Niederhuber Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

John Niederhuber Ownership Network

Ownership Network List of John Niederhuber

No Data

Ownership Network Relation of John Niederhuber

Insider Network Chart

John Niederhuber Owned Company Details

What does Aptevo Therapeutics Inc do?

Who are the key executives at Aptevo Therapeutics Inc?

John Niederhuber is the director of Aptevo Therapeutics Inc. Other key executives at Aptevo Therapeutics Inc include SVP & CFO Daphne Taylor , 10 percent owner Kevin C Tang , and See Remarks Soyoung Kwon .

Aptevo Therapeutics Inc (APVO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aptevo Therapeutics Inc (APVO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aptevo Therapeutics Inc (APVO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aptevo Therapeutics Inc (APVO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aptevo Therapeutics Inc Insider Transactions

No Available Data

John Niederhuber Mailing Address

Above is the net worth, insider trading, and ownership report for John Niederhuber. You might contact John Niederhuber via mailing address: 2273 Research Blvd. Suite 400, Rockville Md 20850.

Discussions on John Niederhuber

No discussions yet.